A Seamless Phase 2A‐Phase 2B Multi‐Center Trial to Test the Benefits of Benfotiamine on the Progression of Alzheimer’s Disease‐Benfoteam: Design and Methods
Work
Year: 2024
Type: article
Abstract: Background Benfotiamine, a prodrug of thiamine, raises blood levels by 50‐100 times to achieve pharmacologic effects. It provides a novel therapeutic direction addressing a well‐characterized brain t... more
Source: Alzheimer s & Dementia
Authors José A. Luchsinger, Howard Feldman, Karen Messer, Steven D. Edland, Gabriel C. Léger +6 more
Institutions Columbia University Irving Medical Center, University of California, San Diego, Cornell University, Burke Medical Research Institute, Weill Cornell Medicine
Cites:
Cited by:
Related to: 10
FWCI:
Citation percentile (by year/subfield):
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: hybrid
APC paid (est): $4,000